Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FQP1X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,732
Award facts
- Contract value 100% obligated
- $40,732.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packaging) under a firm fixed-price contract valued at $40,732.39. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains. As a major healthcare solutions provider, AmerisourceBergen leverages its comprehensive IDC vehicle to deliver brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among the key vendors supporting this strategic procurement initiative.
Quick answers
Who was awarded contract SPE2DR26FQP1X?
SPE2DR26FQP1X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FQP1X worth?
The government has obligated $40,732 on SPE2DR26FQP1X.
Is contract SPE2DR26FQP1X an order under another contract?
Yes. SPE2DR26FQP1X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP1X competed?
The extent of competition for SPE2DR26FQP1X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award